Sex: F
Vaccine: HPV9
Symptoms: Injection site mass, Injection site pain, Pain in extremity, Tenderness
Clinical narrative: lump that emerged that was about an inch-and a half to two inches long, very round; lump that emerged that was about an inch-and a half to two inches long, very round; tender and sore at the injection site/tender and sore arm; tender and sore at the injection site/tender and sore arm; tender and sore at the injection site/tender and sore arm; lump that emerged that was about an inch-and a half to two inches long, very round; This spontaneous report was received from a medical assistant via a company representative and referred to a female patient of unknown age. The patient's concurrent condition, concomitant medications, pertinent medical history, drug reactions/allergies were not reported.  On an unknown date, the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, administered for prophylaxis (strength, dose, lot #, expiry date, anatomical site of administration and route of administration were not provided); On an unknown date, the patient experienced tender and sore at the injection site, started with tender and sore arm and a lump at injection site that emerged about an inch-and a- half to two inches long, very round, but was not (unintelligible) to the touch it was not filled with liquid but like muscle or fat. Tender and sore at the injection site and lump at injection site lasted about a week and disappeared on its own (vaccination site mass and vaccination site pain). On an unknown date, the patient was vaccinated with the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, administered for prophylaxis (strength, dose, lot #, expiry date, anatomical site of administration and route of administration were not provided).  On an unknown date, the patient experienced similar reactions as follows: tender and sore at the injection site, started with tender and sore arm and a lump at injection site that emerged about an inch-and a- half to two inches long, very round, but was not (unintelligible) to the touch it was not filled with liquid but like muscle or fat. Tender and sore at the injection site and lump at injection site lasted about a week and disappeared on its own. On17-NOV-2023, the patient received her third dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, administered for prophylaxis (strength, dose, lot #, expiry date, anatomical site of administration and route of administration were not provided). She reported a similar reaction to what happened after that dose on her previous two doses. She said that on an unknown date in November 2023 (reported as "within 24 hours of the...um..."), the arm was tender and sore at the injection site. The adverse event started with tender and sore arm and a lump at injection site that emerged that was about an inch-and a-half to two inches long, very round, and but was not (unintelligible) to the touch but was not filled with liquid but like muscle or fat. it seemed that it was on the same trajectory. On 04-DEC-2023 (also reported as two weeks after the shot), the patient still had those symptoms. No further information available. The outcome of vaccination site mass (first and second time) and vaccination site pain (first and second time) was considered as recovered. The outcome of vaccination site mass (third time) and vaccination site pain (third time) was not recovered. The action taken with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) regarding vaccination site mass and vaccination site pain was not applicable. The causality between vaccination site mass and vaccination site pain and hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) was unknown.